Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of pharmaceutical composition for treating allergic rhinitis and its preparation method and application

A technology for allergic rhinitis and composition, which is applied in the direction of drug combination, allergic disease, medical formula, etc. It can solve the problems of incomplete relief of symptoms, unquestionable side effects, unavoidable side effects such as saliva, and achieves good application prospects. Significant curative effect, less toxic and side effects

Active Publication Date: 2021-06-18
TEACHING HOSPITAL OF CHENGDU UNIV OF T C M
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, in a large number of clinical observations, it is found that there are some problems in western medicine treatment: first, antihistamines cannot completely relieve symptoms for some patients, especially those with allergic rhinitis complicated with vasomotor rhinitis, and in effective cases, they cannot It is difficult to avoid side effects such as saliva addiction; second, although the curative effect of topical hormones is good, if hormones are used for a long time, the side effects are still unquestionable

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of pharmaceutical composition for treating allergic rhinitis and its preparation method and application
  • A kind of pharmaceutical composition for treating allergic rhinitis and its preparation method and application
  • A kind of pharmaceutical composition for treating allergic rhinitis and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] The preparation of embodiment 1 pharmaceutical composition of the present invention

[0035] 1. Raw materials: 10g Scrophulariae, 4g Magnolia, 5g Mint, 5g Patchouli, 5g Bamboo Leaf Bupleurum, 5g Honeysuckle, 5g Campanulaceae, 3g Cicada, 3g Chrysanthemum, 3g Scutellaria, 2g Licorice.

[0036] 2. Preparation method:

[0037] For the above eleven flavors, take mint, chrysanthemum, magnolia, and patchouli, add 10 times the amount of water, distill and extract for 5 hours, collect 300ml of aromatic water by redistillation, add polysorbate-80 10ml, mix well, set aside, and filter the liquid medicine , set aside; decoct the dregs of the medicine and other seven flavors such as Scrophulariaceae three times, add 6 times the amount of water each time, decoct for 40 minutes, filter, combine the filtrate with the above-mentioned chrysanthemum filtrate, concentrate to a relative density of 1.05 (60°C), add 95% ethanol until the alcohol content reaches 60%, refrigerate for 24 hours,...

Embodiment 2

[0038] The preparation of embodiment 2 pharmaceutical composition of the present invention

[0039] 1. Raw materials: Scrophulariaceae 5g, magnolia 1g, mint 1g, patchouli 2g, bamboo leaves Bupleurum 3g, honeysuckle 1g, bellflower 1g, cicada slough 1g, chrysanthemum 1g, scutellaria baicalensis 1g, licorice 1g.

[0040] 2. Preparation method:

[0041] For the above eleven flavors, take mint, chrysanthemum, magnolia, and patchouli, add 10 times the amount of water, distill and extract for 5 hours, collect 300ml of aromatic water by redistillation, add polysorbate-80 10ml, mix well, set aside, and filter the liquid medicine , set aside; decoct the dregs of the medicine and other seven flavors such as Scrophulariaceae three times, add 6 times the amount of water each time, decoct for 40 minutes, filter, combine the filtrate with the above-mentioned chrysanthemum filtrate, concentrate to a relative density of 1.05 (60°C), add 95% ethanol until the alcohol content reaches 60%, refri...

Embodiment 3

[0042] The preparation of embodiment 3 pharmaceutical composition of the present invention

[0043] 1. Raw materials: 15g Scrophulariae, 8g Magnolia, 10g Mint, 10g Patchouli, 10g Bupleurum bupleurum, 10g Honeysuckle, 10g Campanulaceae, 8g Cicada, 8g Chrysanthemum, 8g Scutellaria, 4g Licorice.

[0044] 2. Preparation method:

[0045]For the above eleven flavors, take mint, chrysanthemum, magnolia, and patchouli, add 10 times the amount of water, distill and extract for 5 hours, collect 300ml of aromatic water by redistillation, add polysorbate-80 10ml, mix well, set aside, and filter the liquid medicine , set aside; decoct the dregs of the medicine and other seven flavors such as Scrophulariaceae three times, add 6 times the amount of water each time, decoct for 40 minutes, filter, combine the filtrate with the above-mentioned chrysanthemum filtrate, concentrate to a relative density of 1.05 (60°C), add 95% ethanol until the alcohol content reaches 60%, refrigerate for 24 hour...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a pharmaceutical composition, which is prepared from the following raw materials: 5-15 parts of Radix Scrophulariae, 1-8 parts of Magnolia Magnolia, 1-10 parts of Peppermint, 1-10 parts of Patchouli, Bupleurum 1‑10 parts, honeysuckle vine 1‑10 parts, bellflower 1‑10 parts, cicada slough 1‑8 parts, chrysanthemum 1‑8 parts, scutellaria baicalensis 1‑8 parts, licorice 1‑4 parts. The invention also provides the preparation method and application of the pharmaceutical composition. The pharmaceutical composition of the invention has significant curative effect on rhinitis, especially rhinitis of latent heat in the lung meridian, has few toxic and side effects, simple preparation process and convenient use, provides a new choice for patients, and has good application prospects.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating allergic rhinitis and a preparation method thereof and [0002] use. Background technique [0003] Allergic rhinitis (AR) is an allergic disease caused by nasal mucosa exposed to allergens, characterized by nasal itching, nasal congestion, sneezing, runny nose and nasal mucosal swelling. The disease has developed into a worldwide disease, with a global prevalence of about 15%-20%, which seriously affects the study, work and personal hygiene of patients, and greatly reduces the quality of life of patients. Allergic rhinitis is the abbreviation of allergic rhinitis, also known as allergic rhinitis. Its pathogenesis includes both visceral deficiency and cold, and lung meridian latent heat, all of which have Yang Qi loss and benefit. [0004] The name of the disease of rhinorrhea was first seen in the "Huangdi Neijing". In the "Suwen·Yin and Yang Yingxiang Dalun" in traditional Chinese m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/808A61P11/02A61P37/08A61K35/64
CPCA61K35/63A61K36/233A61K36/287A61K36/346A61K36/355A61K36/484A61K36/532A61K36/534A61K36/539A61K36/575A61K36/808A61K2236/331A61K2236/51A61K2236/53A61K2236/39A61K2300/00
Inventor 刘莉孙香娟袁强华
Owner TEACHING HOSPITAL OF CHENGDU UNIV OF T C M